This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a Université de Sherbrooke directory, so their publications, courses and email address may be missing. Find their university profile.
Latest funding
- $447,525
Calcineurin Inhibitor in NEuRoloGically deceased donors to decrease kidney delaYed graft function trial (CINERGY) - Vanguard
CIHR · 2020 · Principal investigator
Calcineurin Inhibitor in NEuRoloGically deceased donors to decrease kidney delaYed graft function trial (CINERGY) - Vanguard
Principal investigators: D'Aragon, Frederick; Meade, Maureen O; Selzner, Markus
Keywords: Critical Care; Ischemia-Reperfusion Injury; Kidney Transplantation; Organ Donation; Tacrolimus
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.